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INTRODUCTION
Cervical cancer is one of the preventable cancers, yet globally it is the third most common cancer in women and the seventh overall (1). Between 2000 and 2008, the global incidence of cervical cancer increased from 493 000 to 529 800 and the mortality from 273 000 to 275 000 (1). In North America, there has been a steady decline in the incidence of cervical cancer with rates as low as 10 cases per 100 000, compared to Latin America and the Caribbean with estimated rates of more than 20 cases per 100 000 (2) .
In Trinidad and Tobago, between 1997 and 2006, there were 678 deaths due to cervical cancer (3) and the cervical cancer incidence and mortality rates (for 2012) stood at 13.5% and 12.9%, respectively of all cancers in women (4). For the Eastern Regional Health Authority (ERHA), Trinidad and Tobago, there were 95 cases and 17 deaths from cervical cancer for the period January 1997 to December 2006 (3).
Cervical screening guidelines for the Caribbean region recommend that at a minimum, 80% of women aged 25-50 years who have ever engaged in sexual intercourse should be screened for precancerous cervical lesions. Additionally, women with an abnormal cervical smear result should have repeat cervical screening at consecutive intervals or gynaecological evaluation (5) .
Studies have drawn attention to several challenges with cervical screening programmes. The major concerns are inadequate coverage of the target population and poor follow-up of women with abnormal cervical smears (6, 7) . In light of this situation, technical experts have recommended regular monitoring of core indicators such as coverage of target population and follow-up of women with positive screening results in order to implement effective programmes to achieve the goal of cervical screening (8) .
The aim of this study was to evaluate whether the current cervical screening programme in the ERHA in Trinidad and Tobago was achieving the international benchmarks (8) (9) (10) .
The objectives of the study were: C To identify the number and proportion of women in each age category, with emphasis on the 25-49-year age group, who are accessing cervical screening services at selected health centres. C To describe the frequency distribution of abnormal smears detected in each Pap smear abnormality category. C To determine the outcome of women with abnormal smears who were recommended for either repeat Pap smear or gynaecological evaluation.
SUBJECTS AND METHODS
The study was a retrospective analysis of data from the cervical screening programme at five health centres in eastern Trinidad for the period January 2009 to December 2010 and was conducted during the period June 1 to June 30, 2011. A purposive sampling of one health centre within each of the five clusters in the ERHA was carried out. Each chosen health centre represented the largest population catchment area. The subjects of this study were women, aged 15-69 years, who had a Pap test in 2009 and 2010. In addition, the clients whose cervical smears were abnormal, within the same period, were selected to determine whether outcome of care was based on established guidelines.
A data collection form, adapted from the National Cervical Screening Services Evaluation Monthly Report, was used to extract data for the first objective from the cervical screening registers. The data collected were the number of Pap smears carried out in each age category: 15-24, 25-29, 30-39, 40-49, 50-59 and 60-69 years, the cumulative total of Pap smears carried out, and the types and numbers of abnormal smears detected in each Pap smear abnormality category.
For the second objective, data from clients whose cervical smears were abnormal were collated on a separate extraction form. The form was created based on information from the literature review and was validated by an independent medical officer from another health facility. It was pretested by independent healthcare providers from other health centres and modified as necessary. The Principal Investigator collected all data so standardization was ensured throughout data collection. The information recorded at this stage was clients' identifiers and type of abnormal lesions detected.
Using the same data collection form, data for the third objective were collected from each client's record which was filed at the health centres. The data collected were:
C Whether the client returned for the results of the cervical screening C Whether the client was recommended for a repeat Pap smear C Whether the client followed-up on the request for a repeat Pap smear C Whether the client was recommended for a gynaecological evaluation C Whether the client followed-up on the recommendation for gynaecological evaluation C Description of the client's follow-up care, ie optimal, suboptimal or poor [defined below (6)] C Details of client's demographic data, age, ethnicity, union status, educational level and household income The definition of optimal care is care based on the recommended schedule for an abnormal smear, ie for lowgrade lesions or human papillomavirus (HPV), repeat Pap smear within six to eight months; for high-grade lesions, referral for gynaecological evaluation within six weeks of receipt of abnormal results (6) . Suboptimal care means that the woman had follow-up care but not according to the recommended schedule as stated above. Poor care means that the woman did not follow-up on the recommended schedule for care (6) .
Additional data collection
In the instance where there was no documentation concerning follow-up care on the client's record, the woman was contacted via telephone. A request was made for her recruitment in the study, following which she was asked about the outcome of her cervical screening test. Where efforts to contact the woman were ineffective, it was recorded as lost to follow-up.
The total number of women in each age category per catchment area was provided by the Central Statistical Office. We used the local government boundaries which is similar to the Regional Health Authority boundaries.
Data analysis and ethical considerations
Data were entered into Microsoft Excel, cleaned and imported into SPSS v 12 for analysis. Descriptive and Chisquared analyses were carried out.
Approval for this study was granted by the Ethics Committee of the Faculty of Medical Sciences, The University of the West Indies, St Augustine. The Eastern Regional Health Authority and the County Medical Officers of Health of the county of Nariva/Mayaro and St Andrew/St David granted approval for the research project to be conducted within the healthcare facilities. Informed consent was obtained verbally from study participants who had to be followed-up where there was no documentation concerning outcome of care. Confidentiality was maintained at all stages.
RESULTS

Cervical screening coverage
The cumulative cervical screening coverage for the years 2009 and 2010 was 2600 Pap smears for a population of 28 811 women (9% coverage). Table 1 demonstrates the proportion of cervical smears done in each age group in the county of Nariva/Mayaro. In 2009, 517 cervical smears were done, with proportion ranging from 2.3%-8.6% among the various age groups. The cumulative coverage in the 25-49-year age group stood at 6.8% (n = 346). For 2010, the number of cervical smears done totalled 708, with the proportion of smears per age group ranging from 2.3%-12.9%. The cumulative coverage achieved for the 25-49-year age group was 8.3% (n = 422). If any woman had two Pap smears in the two-year period, it was based on the recommended schedules and was not counted in the total. Table 2 demonstrates the number of cervical smears done for the years 2009 and 2010 in the county of St Andrew/St David. The coverage ranged from 1.6%-5.4% and 1.9%-5.4% for the respective years. The cumulative coverage for the 25-49-year age group for the respective years were 4.2% (n = 411) and 4.9% (n = 478). Table 3 outlines the type and frequency distribution of abnormal Pap smears (n = 155) detected among women from women of the region. With respect to the high-grade lesions, atypical squamous cells -high-grade squamous intraepithelial lesion cannot be excluded (ASC-H), 4.5%, was noted to be the most frequent. Invasive squamous cervical carcinoma was reported in 0.6% of the women. Human papillomavirus was reported in 7.7% of the study population.
Frequency of abnormal smears
Of the 155 women with abnormal smears, 136 (87.7%) were recommended for repeat Pap smear and 19 (12.3%) were referred for gynaecological evaluation. Table 4 describes the summary of the outcome of women who were recommended for repeat Pap smear or Cervical Smears: Coverage and Follow-up ASCUS -atypical squamous cell of undetermined significance, LSIL -lowgrade squamous intra-epithelial lesion, HSIL -high-grade squamous intraepithelial lesion, ASC-H -atypical squamous cells -high-grade squamous intra-epithelial lesion cannot be excluded, AGUS -atypical glandular cells of undetermined significance, InvSqCC -invasive squamous cervical carcinoma, HPV -human papillomavirus the five health centres. It showed that there is a high occurrence of the low-grade lesions, atypical squamous cell of undetermined significance (ASCUS), 68.4%, among the gynaecological evaluation at the selected health centres. The study findings showed that of the total referrals (n = 155), 31.6% had optimal care, 13.5% suboptimal, and 54.8% poor follow-up care. Of the women with poor follow-up care, 36.8% were lost to follow-up. According to Table 5 , Chi-squared analysis indicated a significant relationship between age and follow-up care (p < 0.05).
Chirenje et al conducted a situational analysis of cervical screening services at various countries in the subSaharan regions and found that an average of four Pap smears per month was performed in the primary health centres (11) . In a municipal area of South Africa, Pillay et al reported similar findings with an average of 20 Pap smears monthly performed at different clinics (12) .
Another upper-middle income country, Romania, has also recorded extremely low cervical screening coverage. Research in 2010 found low cervical screening rates in all its regions. These rates ranged from 3.2% to 0.6% with the contributing factors being lack of an organized cervical screening programme and adequate financing for Pap tests (13) .
Regionally, Murillo et al reviewed secondary data concerning cervical screening programmes in Latin America and the Caribbean and found a paucity of data concerning performance indicators for cervical screening programmes (14) . However, Bessler et al reported low screening rates in Jamaica. The study showed that in one parish, only 6.3% of the total population of women 25-54 years had cervical screening for 2004 (15) .
Concerning inadequate follow-up care as reported in this study, a literature review confirms our findings with other studies. Billette-de Villemeur et al reported that out of 1154 women in France referred for follow-up care for ASCUS, more than 75% did not meet the guidelines (7). Dzuba et al also reported from Bolivia that 50% to 80% of women with abnormal cervical smears were lost to follow-up (16) . A similar study by Singhal et al in the United States of America (USA) found that a significant proportion of women were not receiving the care as recommended (6) .
Several studies have highlighted the issues with poor follow-up for cervical screening in developing countries. The contributing factors responsible for this problem in Bolivia were lack of information and tracking systems, poor coordination between screening and treatment level of service, health providers' attitude, and tardiness in communicating results to women (16) . In addition, Arrossi et al found that problems with low coverage were associated with absence of quality control and a lack of monitoring and evaluation (17) .
There were three categories of factors that influence follow-up: personal, procedure/provider/system and ecological/community factors (18) . It is necessary, therefore, that cervical screening programmes which have experienced poor follow-up success conduct knowledge, attitude and practice (KAP) studies among women to determine the factors which hinder compliance. In light of the impending national HPV vaccination thrust for adolescents, it is also important to initiate discussions in order to understand barriers that will hinder participation.
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DISCUSSION
The screening and follow-up management of cervical abnormalities in five health centres of the Eastern Regional Health Authority have been shown to be well below established recommendations. Two thousand six hundred Pap smears were done for a population of 28 811 women (9% coverage) over the two years 2009-2010. The commonest abnormalities found among all age groups were the lowgrade lesions, ASCUS and low-grade squamous intraepithelial lesion (LSIL). There was a small but significant incidence of invasive squamous cervical carcinoma detected within the 30-39-year age category. Of the 155 women who were recommended for further care, 68.3% were not followed-up according to the guidelines. In addition, there was a significant proportion of women (36.8%) who were unable to be contacted, and were described as lost to followup, because of inadequate demographic data. The significant predictor to the outcome of follow-up care was age, with greater proportions of older women receiving follow-up. The low cervical screening coverage of the target population mirrors similar findings from international and regional studies. Significantly, these data from Trinidad and Tobago, a middle income country with a gross domestic product (GDP) of approximately 18 000 USD is comparable to statistics reported from low-income economies such as those in sub-Saharan African countries.
Limitations
The cervical screening coverage was determined from a county perspective rather than from a health centre perspective according to the objective of the study. This was so because data for the target population were only available from a county level.
Data on coverage were collated for only two years and clients' follow-up care for repeat Pap smear was determined for only the first six months and hence a comprehensive description of coverage and follow-up of the women accessing care for cervical screening could not be provided. It is recommended that further study be conducted using an extended period in order to obtain a more comprehensive description of coverage and women with abnormal smears who require follow-up care.
Despite the fact that the sample did not include cervical screening uptake from the private healthcare providers as well as outreach programmes conducted by the local Family Planning Association, the data can be considered a fair estimate of the cervical screening uptake for the region. Key informants from these establishments revealed that estimates of cervical cancer screening coverage at non-governmental organizations are less than 2% per annum.
CONCLUSION
The findings from this research have revealed that the cervical screening services are not maximizing the available resources and as such the target population is not receiving maximum benefit from the programme. Cervical screening services, therefore, should aim at integration of the various components of the programmes, improvement in information and tracking system and an understanding of the challenges which prevent women from accessing cervical screening services. In addition, services should be made more accessible by providing daily walk-in clinics at the health centres with the largest catchment population and mobile services to rural areas. Such strategies will be excellent attempts in achieving the recommended coverage of 80% of the target population and hence the achievement of early detection and treatment of precancerous lesions and the reduction of adverse effects of cervical cancer.
